LivaNova (LIVN) Profit After Tax Growth (3y) (2017 - 2026)
LivaNova (LIVN) Profit After Tax Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 49.66% |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | -7.65% |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 9.79% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 97.37% |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | 15.46% |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | 354.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 354.68% |
| Mar 31, 2026 | 44.62% |
| Dec 31, 2025 | 164.99% |
| Sep 30, 2025 | 31.03% |
| Jun 30, 2025 | 18.21% |
| Mar 31, 2025 | -381.11% |
| Dec 31, 2024 | 134.54% |
| Sep 30, 2024 | 40.25% |
| Jun 30, 2024 | 31.79% |
| Mar 31, 2024 | -10.89% |
| Dec 31, 2023 | 27.20% |
| Sep 30, 2023 | 20.95% |
| Jun 30, 2023 | 26.26% |
| Mar 31, 2023 | -41.84% |
| Dec 31, 2022 | 26.24% |
| Sep 30, 2022 | -74.81% |
| Jun 30, 2022 | 36.85% |
| Mar 31, 2022 | 30.09% |
| Dec 31, 2021 | 71.02% |
| Sep 30, 2021 | -90.61% |